Structural Model for Self-Limiting β-strand Arrangement Within an Alzheimer's Amyloid-β Oligomer
Y. Gao, R. Prasad, P. S. Randolph, J. O. Watzlawik, A. S. Roband, C. Guo, S. M. Stagg, H.-X. Zhou, T. L. Rosenberry, A. K. Paravastu
Abstract
Previous reports revealed that sodium dodecyl sulfate near its critical micelle concentration can drive the assembly of A{beta}42 along an oligomeric pathway. This pathway produces a 150 kDa peptide oligomer (approximately 32 peptide molecules or protomers) that does not aggregate further into amyloid fibrils. Solid-state nuclear magnetic resonance (NMR) spectroscopy revealed structural features distinguishing the 150 kDa oligomer from fibrils. A puzzling feature was the coexistence of parallel and antiparallel {beta}-sheets within the oligomer structure. Here we present new atomic-level structural constraints obtained via solid-state NMR spectroscopy, benefitting from improved resolution via sample concentration by ultracentrifugation. In addition, two-dimensional cryo-electron microscopy (cryo-EM) reconstruction revealed a 4-fold symmetric shape. We propose a structural model to rationalize the solid-sate NMR- and cryo-EM-derived structural constraints. This model has a hollow square cylinder shape, with antiparallel {beta}-sheets formed by residues 33-39 lining the inner walls and parallel {beta}-sheets formed by residues 11-22 lining the outer walls. Within successive layers, the outer {beta}-strands on each side of the square cylinder alternate between two forms: one within a U-shaped protomer and another within L-shaped protomer. Molecular dynamics simulations show that, when the oligomer model is embedded in a lipid membrane, ions permeate through the central pore, with cation selectivity. The model further motivates an assembly pathway-based interpretation that may explain why the 150 kDa oligomer does not undergo further aggregation into amyloid fibrils. Significance StatementA{beta} oligomers are thought to be the most toxic species in Alzheimers disease. Their sizes range from 2 to [~]50 protomers. Most published experimental data on A{beta} oligomers indicate that they, like fibrils, are composed of {beta}-sheets, but it is a mystery why any {beta}-sheet aggregate would exist as a stable oligomer without undergoing further aggregation into fibrils. Here, structural constraints from solid-state NMR and cryo-EM led us to an oligomer model with a hollow square cylinder shape capable of conducting ions when embedded in a lipid membrane. Based on the model, we argue that geometric frustration may distinguish the assembly pathway that produces this oligomer from fibril-forming assembly pathways.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The amyloid concentric β-barrel hypothesis: Models of amyloid beta 42 oligomers and annular protofibrils
H. R. Guy, R. Kayed, S. R. Durell·bioRxiv·Aug 3, 2021
- Out-of-register parallel β-sheets and antiparallel β-sheets coexist in 150 kDa oligomers formed by Aβ(1-42)
Y. Gao, C. Guo, … A. K. Paravastu·bioRxiv·Mar 3, 2020
- Out-of-Register Aβ42 Assemblies as Models for Neurotoxic Oligomers and Fibrils
W. Xi, E. Vanderford, U. Hansmann·bioRxiv·Sep 19, 2017
- Theory of concentric β-barrel structures: models of amyloid beta 42 oligomers, annular protofibrils, and transmembrane channels
Stewart R. Durell, Rakez Kayed, H. Robert Guy·bioRxiv·Dec 20, 2018
- The concentric beta-barrel hypothesis for amyloids: Models of soluble and transmembrane amyloid-beta 42 oligomers and channels composed of identical subunits and GM1 gangliosides.
Stewart R. Durell, Yinon Shafrir, H. Robert Guy·bioRxiv·Mar 23, 2026
- Monomeric amyloid beta-peptide (1-42) significantly populates compact fibril-like conformations
B. Barz, A. K. Buell, S. Nath·bioRxiv·Jun 23, 2020